SCHEMBL18784248

SCHEMBL18784248

CN(C)CCOc1c(CS(=O)(=O)c2ccccc2)cccc1-c1ccoc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 3/20 0.38
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NAT1 P18440 1/20 0.35
GBA1 P04062 1/20 0.35
DRD2 P14416 1/20 0.34
DRD1 P21728 1/20 0.34
DRD4 P21917 1/20 0.34
DRD5 P21918 1/20 0.34
MCL1 Q07820 1/20 0.34
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33
HTR6 P50406 1/20 0.33
METAP2 P50579 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
KMT2A Q03164 1/20 0.33
HRH1 P35367 1/20 0.32
LTA4H P09960 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1648645 0.85 METAP2 (0.42) HTR7ALDH1A1KDM4ESMN1; SMN2NAT1
SCHEMBL18784224 0.85 ALOX5AP (0.37) ALDH1A1KDM4ESMN1; SMN2NAT1MCL1
Hydrochloric Acid SCHEMBL1647980 0.84 METAP2 (0.42) HTR7ALDH1A1KDM4ESMN1; SMN2NAT1
SCHEMBL1648086 0.83 METAP2 (0.41) ALDH1A1KDM4ESMN1; SMN2NAT1MCL1
SCHEMBL18784219 0.80 METAP2 (0.36) ALDH1A1KDM4ESMN1; SMN2NAT1GBA1
SCHEMBL18784217 0.80 GBA1 (0.34) ALDH1A1KDM4ESMN1; SMN2NAT1GBA1
SCHEMBL1648648 0.79 ALDH1A1 (0.35) ALDH1A1KDM4ESMN1; SMN2GBA1METAP2
Hydrochloric Acid SCHEMBL14717753 0.79 ALDH1A1 (0.34) ALDH1A1KDM4ESMN1; SMN2GBA1METAP2
SCHEMBL18784246 0.78 HTR7 (0.43) HTR7ALDH1A1KDM4ESMN1; SMN2GBA1
SCHEMBL1648904 0.76 PDK2 (0.38) NAT1MCL1METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2486004-B1 SULPHONE COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY ZAFGEN INC (US) 2017-05-03 EP claimed